On perinatal risk precision in the first trimester of pregnancy in relation to nuchal translucency and the biochemical analysis of maternal serum

Clinical Laboratory

Volumn 48, Issue 7-8, 2002, Pages 421-423

  Alkier, Rudolf ^a   Denk, Roland ^a   Eiben, Bernd ^a   Ellis, Andy ^a   Grunow, Gabriele ^a   Groß, Ulrike ^a   Hackeloer B J ^a   Huesgen, Gert ^a   Kaisenberg, Constantin V ^a   Kiralp, Hülya ^a   Knüppel, Wolfgang ^a   Kozlowski, Peter ^a   Kossakiewicz, A ^a   Lüthgens, Kai ^a   Merz, Eberhard ^a   Meyberg, Horst ^a   Nicolaides, Kypros ^a   Nuber, Bernd ^a   Osmers, Rüdiger ^a   Pruggmayer, Michael ^a   Schwärzler, Peter ^a   Schwarzenberg, A ^a   Spencer, Kevin ^a   Sucka, Herbert ^a   Wagner, Helmut ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ARTICLE; BIOCHEMISTRY; CERTIFICATION; DISEASE PREDISPOSITION; FEMALE; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GENETIC COUNSELING; GESTATIONAL AGE; HUMAN; MATERNAL SERUM; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; PERINATAL CARE; PRENATAL DIAGNOSIS; QUALITY CONTROL; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY ANALYSIS; STANDARDIZATION; THERMOSTABILITY;

BLOOD CHEMICAL ANALYSIS; CERTIFICATION; FEMALE; GERMANY; HUMANS; MUSCLES; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; REFERENCE STANDARDS; RISK ASSESSMENT; ULTRASONOGRAPHY, PRENATAL;

EID: 18444392399     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchaltranslucency thickness at 10-14 weeks of gestation
2. Wissenschaftlicher Beirat der Bundesärztekammer Richtlinien zur pränatalen Diagnostik von Krankheiten und Krankheitsdispositionen
3. Rapid prenatal diagnosis of aneuploidies in uncultured amniocytes by fluorescence in situ hybridization
4. The 11-14 week scan - Diagnosis of fetal abnormalities
5. A rapid screening program for trisomy 21 at 10-14 weeks using fetal nuchal tranclucency, maternal serum free β-hCG and PAPP-A
6. One stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation